Nabriva Therapeutics AG

Founded in 2006
Employees: 52

Nabriva.com

Description :

Nabriva Therapeutics is a company focused on developing a new class of antibiotics, pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant pathogens.

Headquarters :

Leberstrasse 20 1110 Vienna

Nabriva story - bacterial pneumonia antibiotic

Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic

Austrian Biotech Scores a Phase III Win in the Fight Against Antibiotic Resistance

This Biotech Sticks Bacterial Proteins Together to Fight Antibiotic Resistance

Irish Pneumonia Antibiotic Gets Positive Phase III Results

Another Pneumonia Antibiotic is Close to Treating Patients

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.